Braden M. Leonard - 04 Dec 2025 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
10%+ Owner
Signature
Braden M Leonard
Issuer symbol
ADVM
Transactions as of
04 Dec 2025
Transactions value $
-$2,200,372
Form type
4
Filing time
05 Dec 2025, 18:20:04 UTC
Previous filing
03 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Leonard Braden Michael 10%+ Owner 65 E CEDAR - SUITE 2, ZIONSVILLE Braden M Leonard 05 Dec 2025 0001373603

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Sale -$2.2M -525K -21.13% $4.19 1.96M 04 Dec 2025 Holdings of BML Investment Partners, L.P. F1, F2
holding ADVM Common Stock 192K 04 Dec 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Braden M. Leonard is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
F2 Represents shares sold in multiple transactions at a price of $4.1947 per share. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the transactions at the price sold.